⚠ Evidence warning: Clinical trials or other evidence do not support the claims that beta-alanine adds to the effects of caffeine and of nitrate, and gives vegetarians larger performance gains. This page keeps it as a report of what people, websites or other media say.

Beta-Alanine for Endurance and High-Intensity Exercise

Beta Alanine for Endurance — scientific infographic poster

Beta-alanine is one of the most important misconceptions in sports nutrition: despite the shared name, it is biochemically and pharmacologically nothing like L-alanine. Beta-alanine (3-aminopropanoic acid) is a structural isomer in which the amino group sits on the beta-carbon rather than the alpha-carbon, and crucially, it is not incorporated into proteins. Its sole established role in human physiology is as the rate-limiting precursor for carnosine (beta-alanyl-L-histidine), a dipeptide present at high concentrations in skeletal muscle, where it functions as an intramuscular pH buffer during anaerobic exercise. Beta-alanine supplementation raises muscle carnosine concentration: by 58.8% at 4 weeks and 80.1% at 10 weeks in one trial (Hill 2007), and by 23-39% across three muscles after 5-6 weeks at 4.8 g/day in another (Baguet 2009) — an effect achievable through no dietary route except concentrated meat consumption, and not achievable at all through L-alanine supplementation. About two decades of well-controlled randomized trials have established that beta-alanine produces a small but reliable improvement in exercise capacity for efforts in the 1-4 minute range (where intramuscular pH drops are most performance-limiting), and the Australian Institute of Sport lists it among its six Group A performance supplements. The 2015 position stand of the International Society of Sports Nutrition (ISSN) also supports it for exercise performance.


Table of Contents

  1. Beta-Alanine vs L-Alanine — A Completely Different Molecule
  2. Carnosine — The Actual Target of Beta-Alanine Supplementation
  3. The Intramuscular pH-Buffering Mechanism
  4. Why Beta-Alanine Is the Rate-Limiter for Carnosine Synthesis
  5. Dose and Loading Protocols (Harris / Hoffman)
  6. The Paraesthesia ("Tingle") Effect
  7. Documented Exercise-Capacity Effects
  8. Non-Responders and the Vegetarian Effect
  9. Other Putative Roles of Carnosine (Beyond Exercise)
  10. Stacking with Other Sports Supplements
  11. Cautions
  12. Key Research Papers
  13. Connections
  14. Featured Videos

Beta-Alanine vs L-Alanine — A Completely Different Molecule

The most important conceptual point about beta-alanine is that it is, despite the shared name, a fundamentally different molecule from L-alanine and serves a non-overlapping biological role. The two share only the molecular formula (C3H7NO2) and a stoichiometric similarity. Their biochemistry, transport, metabolism, and clinical applications are entirely separate.

The structural distinction is the position of the amino group relative to the carboxylic acid:

The two amino acids are also transported differently. L-alanine uses the System A and System ASC sodium-dependent transporters (SNAT1, SNAT2, ASCT1, ASCT2). Beta-alanine uses a completely different transporter, the taurine/gamma-aminobutyric acid (GABA) transporter family (TauT/SLC6A6), which it shares with taurine and gamma-aminobutyric acid. This is the biochemical reason that taurine and beta-alanine compete for uptake at the muscle cell membrane and at the blood-brain barrier — a fact relevant when stacking these two supplements.

The only metabolic connection between L-alanine and beta-alanine in human physiology is that beta-alanine can be slowly produced from L-aspartate through aspartate decarboxylation in the liver, and from cytosine and uracil (pyrimidine bases) through their catabolic pathway. These endogenous sources produce only modest amounts of beta-alanine — nowhere near enough to saturate muscle carnosine synthesis, which is why oral supplementation produces such striking carnosine increases.

Back to Table of Contents

Carnosine — The Actual Target of Beta-Alanine Supplementation

Carnosine (beta-alanyl-L-histidine) is a dipeptide of beta-alanine and L-histidine connected by a standard peptide bond. It was discovered in 1900 by the Russian biochemist V.S. Gulewitsch in beef extract (hence the name "carnosine" from carnis, Latin for flesh). It is present at high concentrations — 5-25 mmol/kg dry muscle — in skeletal muscle of all vertebrates, with the highest concentrations in the fast-twitch (Type II) fibers that are most dependent on anaerobic glycolysis.

The functional importance of carnosine in muscle was established through the work of Roger Harris and his colleagues in the early 2000s. Three properties make carnosine uniquely well-suited for its buffering role:

Carnosine concentrations vary substantially between individuals, fiber types, and species. Sprinters have higher concentrations than endurance athletes. Type IIx fibers (fastest fast-twitch) have higher concentrations than Type I (slow oxidative). In a study of 149 people (Everaert 2011), men had 36%, 28% and 82% higher concentrations than women in three leg muscles, and vegetarians had 26% lower carnosine in the gastrocnemius than omnivores (meat being the dietary source of preformed beta-alanine). Genetic polymorphisms in carnosine synthetase are proposed to explain some of the remaining individual variability; the same study found muscle carnosine unrelated to the gene for carnosinase (the degradative enzyme, CNDP1) or to plasma carnosinase activity.

Muscle carnosine falls slowly after supplementation stops: Baguet 2009 measured a decline of 2-4% per week, with a return to baseline within 9 weeks at group level (15 weeks in high responders, 6 weeks in low responders). Loading is slow as well: in a 24-week trial, carnosine was still climbing well after week 4 (+11.37 mmol/kg dry muscle at week 4, +21.20 at week 20). This relatively slow turnover is why beta-alanine is dosed continuously rather than only on training/competition days, and why the timing of beta-alanine intake within a day matters very little.

Back to Table of Contents

The Intramuscular pH-Buffering Mechanism

To understand why intramuscular carnosine matters for exercise performance, it helps to understand the proton-accumulation problem during anaerobic exercise.

During high-intensity exercise that exceeds the rate at which oxygen can be supplied and used by the mitochondria, muscle cells rely on anaerobic glycolysis — the conversion of glucose to lactate — for adenosine triphosphate (ATP) production. Each glucose molecule that goes through anaerobic glycolysis yields 2 adenosine triphosphate plus 2 lactate. The lactate is not the cause of the "burn" or the fatigue — it is the protons (H+), which the 2004 Robergs review attributes to adenosine triphosphate breakdown rather than to lactate formation. The lactate is shipped to the liver via the Cori cycle and is, if anything, a useful aerobic fuel for the heart and slow-twitch fibers. The protons are what drop intramuscular pH from 7.0 at rest toward 6.4 at exhaustion.

The pH drop has multiple performance-limiting effects:

Carnosine's role is to absorb protons before they can reach the concentrations that trigger these performance-limiting effects. Each mole of carnosine's imidazole group can buffer one mole of H+, so the total buffering capacity scales linearly with intramuscular concentration. Raising muscle carnosine (by +58.8% at 4 weeks and +80.1% at 10 weeks in Hill 2007) raises the carnosine contribution to total intramuscular buffering capacity in proportion, which is described as enough to delay the onset of severe acidosis by tens of seconds in the 1-4 minute exercise window.

Back to Table of Contents

Why Beta-Alanine Is the Rate-Limiter for Carnosine Synthesis

Carnosine is synthesized intramuscularly by carnosine synthase (ATPGD1, also known as CARNS1), which catalyzes the adenosine triphosphate-dependent condensation of free beta-alanine and free L-histidine. The reaction is:

beta-alanine + L-histidine + adenosine triphosphate → carnosine + adenosine diphosphate + phosphate

Older accounts gave adenosine monophosphate and pyrophosphate as the products. Drozak and colleagues (2010) purified the enzyme and found carnosine forming with a matching amount of adenosine diphosphate instead, which places carnosine synthase in the ATP-grasp family of enzymes.

The reaction depends on both substrates being available at sufficient concentration. The key insight from the Harris 2006 and Hill 2007 studies is that L-histidine is normally present in muscle at saturating concentrations, while beta-alanine is normally present at sub-saturating concentrations. This makes beta-alanine the rate-limiting substrate. Oral histidine loading does not raise muscle carnosine. Oral beta-alanine loading does.

The mathematical implication is straightforward: increasing the bioavailable beta-alanine pool increases the substrate for carnosine synthase, which proportionally increases the muscle carnosine concentration over the weeks-long timescale that the muscle pool requires to equilibrate. The kinetics of the equilibration follow a roughly exponential approach to a new steady-state ceiling. Hill 2007 showed that 4 weeks of loading at 4.8 g/day raised muscle carnosine by 58%, and 10 weeks of loading at the same dose raised it by 80% the additional 6 weeks added much less benefit than the first 4 weeks, consistent with an asymptotic approach to a ceiling.

The diet contains some preformed carnosine and anserine (the methylated carnosine analog found at higher concentrations in poultry and fish), and much of it does not last. Gardner and colleagues (1991) recovered up to 14% of ingested intact carnosine in urine, showing that it crosses the intestine, and then found rapid breakdown after absorption by the blood enzyme carnosinase (CN1, CNDP1). The net effect is that almost all the beta-alanine that reaches muscle for carnosine synthesis must come from supplemental free beta-alanine, not from dietary carnosine. This is why concentrated meat consumption raises muscle carnosine only modestly compared to direct beta-alanine supplementation.

The longest trial found in this review ran 24 weeks: 25 active men were assigned to 6.4 g a day of sustained-release beta-alanine or placebo (Saunders 2017). Carnosine rose +11.37 mmol/kg dry muscle by week 4 and about +20 by weeks 20-24, with wide differences between people (maximal rises from +17.13 to +41.32), none on placebo, and a high-intensity cycling test improved. The authors say this spread suggests something other than beta-alanine supply also has a major influence on muscle carnosine.

Back to Table of Contents

Dose and Loading Protocols (Harris / Hoffman)

The usual beta-alanine loading protocols trace to the Harris 2006 study and to later trials such as Hoffman 2008, a training trial in college football players. The 2015 ISSN position stand by Trexler and colleagues states that daily supplementation with 4 to 6 g for at least 2 to 4 weeks has been shown to improve exercise performance, and that tingling can be attenuated by divided lower doses (1.6 g) or a sustained-release formula. The protocols described are:

Doses above 6 g/day are described as not producing proportionally greater muscle carnosine elevation. Blancquaert and colleagues (2016; mouse work plus recombinant mouse and human enzymes) report that only 3-6% of ingested beta-alanine is used for carnosine synthesis, and that the rest can be routed to oxidation by two transaminase enzymes in liver and kidney, 4-aminobutyrate-2-oxoglutarate transaminase and alanine-glyoxylate transaminase. Doses above 10 g/day are described as wasted and dramatically increase paraesthesia without performance benefit.

Back to Table of Contents

The Paraesthesia ("Tingle") Effect

The most distinctive feature of beta-alanine supplementation is the harmless paraesthesia effect that occurs within 15-30 minutes of taking a bolus dose larger than approximately 800 mg. It is described variously as "pins and needles," "skin tingles," or a "tropical itch" sensation, typically felt in the face, neck, hands, and torso. It subsides within 30-60 minutes and produces no lasting effect. Athletes initially mistake it for an allergic reaction or a stimulant effect; it is neither.

The mechanism is the activation of the MrgprD receptor (Mas-related G-protein-coupled receptor member D), a recently discovered class of GPCR expressed on a subset of cutaneous C-fiber sensory neurons. Beta-alanine is one of the only known endogenous ligands of MrgprD, and high plasma beta-alanine concentrations transiently depolarize MrgprD-expressing neurons, producing the tingle sensation. The same MrgprD pathway is also involved in itch sensation, which is why some users describe the sensation as itchy rather than tingly.

Practical management of paraesthesia includes:

The paraesthesia is harmless and reversible. No serious adverse events have been linked to it in long-term studies. The clinical significance is essentially zero — it is a marker of the dose having been absorbed, not a sign of toxicity. Users who find it intolerable can use slow-release formulations to eliminate it entirely.

Back to Table of Contents

Documented Exercise-Capacity Effects

The Saunders 2017 British Journal of Sports Medicine meta-analysis (40 studies, 70 individual exercise outcomes, n=1,461 participants) is the largest aggregation of beta-alanine exercise trials. It reports a small overall effect size of 0.18 (95% confidence interval 0.08 to 0.28). Within efforts of 0.5-10 minutes, tests to exhaustion improved (effect size 0.50, confidence interval 0.25 to 0.75), while timed performance did not clearly improve (0.11, confidence interval -0.20 to 0.42). Taking sodium bicarbonate as well gave the largest effect against placebo (0.43, confidence interval 0.22 to 0.64). With the earlier Hobson 2012 meta-analysis (15 manuscripts, 360 participants), the picture by duration is:

Real-world translation in elite athletes is modest but meaningful. A 4% improvement in a 2000m rowing time would mean about 14 seconds faster on an elite 6:00 erg time — a margin described as the difference between qualifying for and missing the Olympic team. For recreational athletes, the practical benefit is "a few more reps" or "a few more seconds" in the late stages of glycolytically demanding sessions. Beta-alanine is not a transformative supplement — it does not make slow athletes fast — but it produces a small reliable edge in the specific exercise domain where carnosine buffering matters.

Back to Table of Contents

Non-Responders and the Vegetarian Effect

Muscle carnosine rises differ widely between people: Baguet 2009 divided subjects into high responders (+55%) and low responders (+15%). Several mechanisms have been proposed:

Conversely, vegetarians are the population most likely to show large beta-alanine responses. Because vegetarian diets contain essentially no preformed carnosine and minimal beta-alanine (which is concentrated in muscle meat), vegetarians typically have lower baseline muscle carnosine than omnivores (26% lower in the gastrocnemius in Everaert 2011). Beta-alanine supplementation in vegetarian athletes therefore produces larger relative increases and larger associated performance improvements. The 2007 Derave trial in trained sprinters showed substantial benefit. The ISSN position stand says vegetarians have greater increases in carnosine concentrations than carnivores; a figure of approximately 50% larger responses is also quoted.

Back to Table of Contents

Other Putative Roles of Carnosine (Beyond Exercise)

Beyond its established role as a muscle pH buffer, carnosine has additional biological properties that are areas of active research, though clinical translations remain incomplete:

For the well-established role of beta-alanine in exercise specifically, the evidence base is strong. The other potential applications remain promising but unproven at clinical scale. These findings do not show beta-alanine to be an anti-aging or neuroprotection supplement — the demonstrated use case is exercise capacity in glycolytically demanding sport.

Back to Table of Contents

Stacking with Other Sports Supplements

Beta-alanine is one of the evidence-supported sports supplements alongside creatine monohydrate, caffeine, sodium bicarbonate, and nitrates (beetroot); all five are on the Australian Institute of Sport's Group A list, which also includes glycerol. These five have independent mechanisms and are often combined:

For more on the broader sports nutrition landscape, see our pages on Leucine (for muscle protein synthesis) and Glutamine (for recovery and gut barrier function).

Back to Table of Contents

Cautions

Back to Table of Contents

Key Research Papers

  1. Harris RC, Tallon MJ, Dunnett M, et al. (2006). The absorption of orally supplied beta-alanine and its effect on muscle carnosine synthesis in human vastus lateralis. Amino Acids 30(3):279-289. — DOI: 10.1007/s00726-006-0299-9. — doi:10.1007/s00726-006-0299-9
  2. Hill CA, Harris RC, Kim HJ, et al. (2007). Influence of beta-alanine supplementation on skeletal muscle carnosine concentrations and high intensity cycling capacity. Amino Acids 32(2):225-233. — DOI: 10.1007/s00726-006-0364-4. — doi:10.1007/s00726-006-0364-4
  3. Hoffman J, Ratamess NA, Faigenbaum AD, et al. (2008). Short-duration beta-alanine supplementation increases training volume and reduces subjective feelings of fatigue in college football players. Nutrition Research 28(1):31-35. — DOI: 10.1016/j.nutres.2007.11.004. — doi:10.1016/j.nutres.2007.11.004
  4. Trexler ET, Smith-Ryan AE, Stout JR, et al. (2015). International Society of Sports Nutrition position stand: Beta-alanine. Journal of the International Society of Sports Nutrition 12:30. — DOI: 10.1186/s12970-015-0090-y. — doi:10.1186/s12970-015-0090-y
  5. Saunders B, Elliott-Sale K, Artioli GG, et al. (2017). Beta-alanine supplementation to improve exercise capacity and performance: a systematic review and meta-analysis. British Journal of Sports Medicine 51(8):658-669. — DOI: 10.1136/bjsports-2016-096396. — doi:10.1136/bjsports-2016-096396
  6. Boldyrev AA, Aldini G, Derave W (2013). Physiology and pathophysiology of carnosine. Physiological Reviews 93(4):1803-1845. — DOI: 10.1152/physrev.00039.2012. — doi:10.1152/physrev.00039.2012
  7. Derave W, Ozdemir MS, Harris RC, et al. (2007). Beta-Alanine supplementation augments muscle carnosine content and attenuates fatigue during repeated isokinetic contraction bouts in trained sprinters. Journal of Applied Physiology 103(5):1736-1743. — DOI: 10.1152/japplphysiol.00397.2007. — doi:10.1152/japplphysiol.00397.2007
  8. Stout JR, Cramer JT, Mielke M, et al. (2006). Effects of twenty-eight days of beta-alanine and creatine monohydrate supplementation on the physical working capacity at neuromuscular fatigue threshold. Journal of Strength & Conditioning Research 20(4):928-931. — DOI: 10.1519/R-19655.1. — PubMed PMID: 17194255
  9. Decombaz J, Beaumont M, Vuichoud J, et al. (2012). Effect of slow-release beta-alanine tablets on absorption kinetics and paresthesia. Amino Acids 43(1):67-76. — DOI: 10.1007/s00726-011-1169-7. — doi:10.1007/s00726-011-1169-7
  10. Sale C, Saunders B, Harris RC (2010). Effect of beta-alanine supplementation on muscle carnosine concentrations and exercise performance. Amino Acids 39(2):321-333. — DOI: 10.1007/s00726-009-0443-4. — doi:10.1007/s00726-009-0443-4
  11. Liu Q, Sikand P, Ma C, et al. (2012). Mechanisms of itch evoked by beta-alanine. Journal of Neuroscience 32(42):14532-14537. — DOI: 10.1523/JNEUROSCI.3509-12.2012. — doi:10.1523/JNEUROSCI.3509-12.2012
  12. Stegen S, Bex T, Vervaet C, et al. (2014). Beta-alanine dose for maintaining moderately elevated muscle carnosine levels. Medicine & Science in Sports & Exercise 46(7):1426-1432. — DOI: 10.1249/MSS.0000000000000248. — doi:10.1249/MSS.0000000000000248
  13. Hobson RM, Saunders B, Ball G, Harris RC, Sale C (2012). Effects of beta-alanine supplementation on exercise performance: a meta-analysis. Amino Acids 43(1):25-37. — PubMed PMID: 22270875
  14. Saunders B, de Salles Painelli V, de Oliveira LF, et al. (2017). Twenty-four weeks of beta-alanine supplementation on carnosine content, related genes, and exercise. Medicine & Science in Sports & Exercise 49(5):896-906. — PubMed PMID: 28157726
  15. Baguet A, Reyngoudt H, Pottier A, et al. (2009). Carnosine loading and washout in human skeletal muscles. Journal of Applied Physiology 106(3):837-842. — PubMed PMID: 19131472
  16. Everaert I, Mooyaart A, Baguet A, et al. (2011). Vegetarianism, female gender and increasing age, but not CNDP1 genotype, are associated with reduced muscle carnosine levels in humans. Amino Acids 40(4):1221-1229. — PubMed PMID: 20865290
  17. Dolan E, Swinton PA, Painelli VS, et al. (2019). A systematic risk assessment and meta-analysis on the use of oral beta-alanine supplementation. Advances in Nutrition 10(3):452-463. — PubMed PMID: 30980076
  18. Drozak J, Veiga-da-Cunha M, Vertommen D, Stroobant V, Van Schaftingen E (2010). Molecular identification of carnosine synthase as ATP-grasp domain-containing protein 1 (ATPGD1). Journal of Biological Chemistry 285(13):9346-9356. — PubMed PMID: 20097752
  19. Blancquaert L, Baba SP, Kwiatkowski S, et al. (2016). Carnosine and anserine homeostasis in skeletal muscle and heart is controlled by beta-alanine transamination. Journal of Physiology 594(17):4849-4863. — PubMed PMID: 27062388
  20. Gardner ML, Illingworth KM, Kelleher J, Wood D (1991). Intestinal absorption of the intact peptide carnosine in man, and comparison with intestinal permeability to lactulose. Journal of Physiology 439:411-422. — PubMed PMID: 1910085
  21. Robergs RA, Ghiasvand F, Parker D (2004). Biochemistry of exercise-induced metabolic acidosis. American Journal of Physiology — Regulatory, Integrative and Comparative Physiology 287(3):R502-R516. — PubMed PMID: 15308499
  22. Abe H (2000). Role of histidine-related compounds as intracellular proton buffering constituents in vertebrate muscle. Biochemistry (Moscow) 65(7):757-765. — PubMed PMID: 10951092

PubMed Topic Searches

  1. PubMed: Beta-alanine and muscle carnosine
  2. PubMed: Beta-alanine and exercise performance
  3. PubMed: Carnosine intramuscular pH buffering
  4. PubMed: Beta-alanine paraesthesia mechanism
  5. PubMed: Carnosinase and beta-alanine non-responders
  6. PubMed: Carnosine anti-glycation and antioxidant roles

Back to Table of Contents

Connections

Back to Table of Contents